| Revenue Per Share | 41.46 | 32.53 | 23.6 | 46.45 | 45.23 | 36.95 | 34.3 | 36.68 |
| Net Income Per Share | 3.26 | 2.83 | -2.38 | 1.73 | 1.84 | 4.16 | 3.98 | 7.24 |
| Operating Cash Flow Per Share | -0.65 | 3.71 | 1.56 | 4.22 | 4.55 | 3.32 | 4.68 | -0.22 |
| Free Cash Flow Per Share | -1.42 | 3.06 | 0.93 | 2.3 | 2.16 | 2.21 | 4.02 | -0.98 |
| Cash Per Share | 8.91 | 6.76 | 11.86 | 19.25 | 19.22 | 18.36 | 15.29 | 11.76 |
| Book Value Per Share | 12.37 | 14.65 | 14.09 | 34.55 | 33.45 | 33.09 | 25.27 | 28.55 |
| Tangible Book Value Per Share | 9.26 | 11.69 | 10.79 | 28.86 | 27.84 | 27.52 | 21.44 | 23.96 |
| Shareholders Equity Per Share | 8.7 | 11.74 | 10.07 | 29.68 | 28.84 | 29.03 | 23.19 | 22.28 |
| Interest Debt Per Share | 47.52 | 34.62 | 43.89 | 49.55 | 43.98 | 37.26 | 37.6 | 42.84 |
| Market Cap | 492.21M | 727.80M | 252.33M | 88.37M | 109.21M | 157.40M | 95.68M | 57.33M |
| Enterprise Value | 1.21B | 1.27B | 813.01M | 604.00M | 539.15M | 495.52M | 496.96M | 542.55M |
| PE Ratio | 7.64 | 12.39 | -5.68 | 2.75 | 3.11 | 1.91 | 1.23 | 0.47 |
| Price to Sales Ratio | 0.6 | 1.08 | 0.57 | 0.1 | 0.13 | 0.22 | 0.14 | 0.09 |
| P/OCF Ratio | -38.18 | 9.46 | 8.68 | 1.13 | 1.26 | 2.4 | 1.04 | -15.31 |
| P/FCF Ratio | -17.58 | 11.49 | 14.59 | 2.07 | 2.66 | 3.61 | 1.21 | -3.46 |
| PB Ratio | 2.87 | 2.99 | 1.34 | 0.16 | 0.2 | 0.27 | 0.21 | 0.15 |
| PTB Ratio | 2.87 | 2.99 | 1.34 | 0.16 | 0.2 | 0.27 | 0.21 | 0.15 |
| EV to Sales | 1.48 | 1.88 | 1.85 | 0.7 | 0.63 | 0.68 | 0.74 | 0.87 |
| Enterprise Value over EBITDA | 7.07 | 8.25 | -18.31 | 4.67 | 3.77 | 4.14 | 4.25 | 4.42 |
| EV to Operating Cash Flow | -93.9 | 16.5 | 27.96 | 7.72 | 6.22 | 7.55 | 5.42 | -144.87 |
| EV to Free Cash Flow | -43.25 | 20.04 | 46.99 | 14.16 | 13.12 | 11.38 | 6.3 | -32.77 |
| Earnings Yield | 0.13 | 0.08 | -0.18 | 0.36 | 0.32 | 0.52 | 0.82 | 2.14 |
| Free Cash Flow Yield | -0.06 | 0.09 | 0.07 | 0.48 | 0.38 | 0.28 | 0.82 | -0.29 |
| Debt to Equity | 5.21 | 2.8 | 4.16 | 1.59 | 1.45 | 1.22 | 1.54 | 1.82 |
| Debt to Assets | 0.64 | 0.56 | 0.63 | 0.49 | 0.47 | 0.44 | 0.49 | 0.51 |
| Net Debt to EBITDA | 4.19 | 3.52 | -12.63 | 3.99 | 3.01 | 2.83 | 3.44 | 3.95 |
| Current Ratio | 8.11 | 7.8 | 38.53 | 29.2 | 27.32 | 18.03 | 16.76 | 18.18 |
| Interest Coverage | 3.01 | 3.23 | -0.94 | 2.22 | 1.84 | 0.44 | 1.65 | 1.71 |
| Income Quality | -0.16 | 1.06 | -0.38 | 2.44 | 1.55 | 0.65 | 2.2 | -0.03 |
| Dividend Yield | 0.02 | 0 | 0 | 0.05 | 0.03 | 0.02 | 0.01 | 0 |
| Payout Ratio | 0.14 | 0 | -0.03 | 0.14 | 0.11 | 0.04 | 0.01 | 0 |
| SG&A to Revenue | 0.46 | 0.47 | 0.62 | 0.51 | 0.62 | 0.99 | 1.02 | 0.99 |
| R&D to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangibles to Total Assets | 0.04 | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | 0.05 | 0.06 |
| Capex to Operating Cash Flow | -1.17 | 0.18 | 0.41 | 0.45 | 0.53 | 0.34 | 0.14 | -3.42 |
| Capex to Revenue | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | 0.03 | 0.02 | 0.02 |
| Capex to Depreciation | 0.72 | 0.68 | 0.48 | 1.28 | 1.77 | 1.03 | 1.6 | 1.22 |
| Stock-based Comp to Revenue | 0 | 0 | 0.06 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Graham Number | 25.29 | 27.35 | N/A | 34.02 | 34.57 | 52.14 | 45.57 | 60.26 |
| ROIC | 0.08 | 0.08 | -0.03 | 0.04 | 0.03 | 0.01 | 0.02 | 0.12 |
| Return on Tangible Assets | 0.05 | 0.05 | -0.04 | 0.02 | 0.02 | 0.05 | 0.06 | 0.1 |
| Graham Net Net | -18.73 | -12.75 | -15.32 | -13.1 | -9.06 | -3.66 | -7.54 | -11.65 |
| Working Capital | 1.05B | 873.55M | 987.27M | 1.24B | 1.21B | 1.15B | 1.04B | 941.70M |
| Tangible Asset Value | 182.70M | 242.45M | 201.30M | 534.64M | 530.65M | 543.57M | 420.27M | 405.12M |
| Net Current Asset Value | 38.32M | 95.28M | 26.19M | 134.71M | 191.09M | 267.16M | 163.56M | 129.73M |
| Invested Capital | 1215774000 | 1056222000 | 1173166000 | 1586055000 | 1459030000 | 1375434000 | 1209491000 | 1109510000 |
| Average Receivables | 499.41M | 427.84M | 429.26M | 444.16M | 445.21M | 453.63M | 452.82M | 450.37M |
| Average Payables | 18.00M | 12.59M | 18.26M | 27.75M | 30.45M | 30.11M | 27.42M | 23.20M |
| Average Inventory | 362.23M | 340.86M | 388.35M | 413.91M | 379.03M | 330.84M | 284.56M | 259.45M |
| Days Sales Outstanding | 246.62 | 241.48 | 339.5 | 190.51 | 185.94 | 225.74 | 247.5 | 264.55 |
| Days Payables Outstanding | 40.14 | 33.89 | 24.5 | 31.26 | 36.05 | 62.39 | 63.38 | 64.7 |
| Days of Inventory on Hand | 731.6 | 776.02 | 805.28 | 517.42 | 486.02 | 715.61 | 663.06 | 665.74 |
| Receivables Turnover | 1.48 | 1.51 | 1.08 | 1.92 | 1.96 | 1.62 | 1.47 | 1.38 |
| Payables Turnover | 9.09 | 10.77 | 14.9 | 11.67 | 10.13 | 5.85 | 5.76 | 5.64 |
| Inventory Turnover | 0.5 | 0.47 | 0.45 | 0.71 | 0.75 | 0.51 | 0.55 | 0.55 |
| ROE | 0.38 | 0.24 | -0.24 | 0.06 | 0.06 | 0.14 | 0.17 | 0.33 |
| Capex Per Share | 0.77 | 0.66 | 0.63 | 1.92 | 2.39 | 1.12 | 0.66 | 0.76 |